null - FindTrial

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-000420-34-FR

Enrollment

500

Registered

2015-06-22

Start date

2015-02-04

Completion date

Unknown

Last updated

2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 18.0 Level: HLGT Classification code 10024970 Term: Respiratory tract infections System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders

Interventions

Trade Name: Pyostacine Product Name: pristinamycine Pharmaceutical Form: Film-coated tablet INN or Proposed INN: PRISTINAMYCIN CAS Number: 11006-49-8 Concentration unit: mg milligram(s) Concentration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France, Morocco, Tunisia

Contacts

Public ContactDirection des Opérations Cliniques

sanofi-aventis France

Public-Registry-MA-France@sanofi.com0 800 222 555

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026